DUBLIN, August 14, 2017 /PRNewswire/ --
The "Worldwide Aortic Aneurysm Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering.
The Global Aortic Aneurysm Market is estimated to witness a CAGR of 6.6% during the forecast period 2017-2023. The aortic aneurysm market is analyzed based on three segments - type, product types, and regions.
The increasing lifestyle diseases and smoking population are the factors that increase the chances for aortic aneurysm. Along with this, the growing aging population, favorable reimbursement, and technological advancements in products are driving the growth of the aortic aneurysm market. However, lack of awareness about the disease, stringent regulatory approval procedures, and risk associated with the procedure are hampering the growth of the market. The main unmet need in the market is endoleaking, which increases the mortality rate.
Currently, the market players are developing technologically advanced stent grafts for the treatment of complex aortic aneurysm repairs. The EVAR segment contributed more than 70% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the aortic aneurysm market in the future.
The market of aortic aneurysm is dominated by Cook Medical, Medtronic PLC, and W.L. Gore and Associates, who occupy around 85% of the market share. Other small players are adopting various strategies to increase their market share. Endologix acquired Trivascular to expand its product portfolio, thereby being able to address the current and future needs in the aortic aneurysm market.
Key Topics Covered:
1 Industry Outlook
2 Report Outline
3 Market Snapshot
4 Market Outlook
5 Market Characteristics
5.2 Symptoms of Aortic Aneurysm
5.3 Market Dynamics
220.127.116.11 Rising geriatric population
18.104.22.168 High prevalence of tobacco smoking
22.214.171.124 Growing acceptance for minimally invasive endovascular surgeries
126.96.36.199 Favorable reimbursement conditions
188.8.131.52 Market expansion opportunities in emerging nations
184.108.40.206 Mergers & acquisitions
220.127.116.11 Increasing clinical trials
18.104.22.168 Stringent regulations for approval
22.214.171.124 Risk associated with the procedure
126.96.36.199 Lack of awareness
5.4 DRO - Impact Analysis
5.5 Key Stakeholders
6 Types: Market Size and Analysis
6.2 Abdominal Aortic Aneurysm
6.2.1 Procedure Type
188.8.131.52 Open surgery
184.108.40.206 Abdominal endovascular aneurysm repair
6.2.2 Location Types
6.3 Thoracic Aortic Aneurysm
6.3.1 Procedure Type
220.127.116.11 Open surgery
18.104.22.168 Thoracic endovascular aortic aneurysm
6.3.2 Location Types
7 Products: Market Size and Analysis
7.2 Stent Grafts
8 Regions: Market Size and Analysis
9 Competitive Landscape
10 Vendors Profile
10.1 MicroPort Scientific Corporation
10.2 Medtronic Plc
10.3 Terumo Corp.
10.4 Endologix Inc.
11 Companies to Watch For
11.1 Cook Medical Inc.
11.2 W.L. Gore & Associates
11.3 Maquet GmbH (Getinge Group)
11.4 Jotec GmbH
11.5 Boston Scientific Corp.
11.6 Lombard Medical Technologies PLC
For more information about this report visit https://www.researchandmarkets.com/research/bnwsgm/worldwide_aortic
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets